{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:05:01Z","timestamp":1789981501473,"version":"4.0.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ5617"],"award-info":[{"award-number":["2024JJ5617"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ30920"],"award-info":[{"award-number":["2022JJ30920"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["Y-NESTLE2022ZD-0369"],"award-info":[{"award-number":["Y-NESTLE2022ZD-0369"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Aberrant expression of EphA2 (Ephrin receptor A2) in gastric cancer (GC) promotes chemoresistance by suppressing ferroptosis, yet the underlying mechanism remains poorly defined. In this study, we show that EphA2 confers resistance to platinum-based chemotherapy by suppressing ferroptosis through redox homeostasis regulation. Mechanistically, EphA2 directly phosphorylates and activates the deubiquitinase USP38, which in turn stabilizes SLC7A11 by preventing its proteasomal degradation. Elevated SLC7A11 sustains intracellular glutathione homeostasis, attenuates lipid peroxidation, and limits reactive oxygen species accumulation, thereby enabling GC cells to evade ferroptotic cell death under chemotherapeutic stress. Importantly, genetic or pharmacological disruption of the EphA2-USP38 interaction leads to SLC7A11 destabilization, excessive ROS accumulation, ferroptosis induction, and restoration of chemosensitivity. Together, these findings identify the EphA2-USP38\/ROS axis as a key determinant of oxaliplatin resistance in GC and highlight a promising therapeutic target for overcoming chemotherapy resistance by reactivating ferroptosis.<\/jats:p>","DOI":"10.1007\/s00018-026-06345-4","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:12:47Z","timestamp":1785366767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of EphA2 triggers ferroptosis by disrupting USP38mediated SLC7A11 stabilization in chemoresistant gastric cancer"],"prefix":"10.1007","volume":"83","author":[{"given":"Runsha","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1516-7036","authenticated-orcid":false,"given":"Chen","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"6345_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F, Global Cancer Statistics 2020 (2021) GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"6345_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3322\/caac.21657","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD (2021) Current treatment and recent progress in gastric cancer. CA Cancer J Clin 71:264\u2013279. https:\/\/doi.org\/10.3322\/caac.21657","journal-title":"CA Cancer J Clin"},{"key":"6345_CR3","doi-asserted-by":"publisher","first-page":"e747","DOI":"10.1002\/ctm2.747","volume":"12","author":"X Xue","year":"2022","unstructured":"Xue X, Ma L, Zhang X, Xu X, Guo S, Wang Y, Qiu S, Cui J, Guo W, Yu Y, Sun F, Shi Y, Wang J (2022) Tumour cells are sensitised to ferroptosis via RB1CC1-mediated transcriptional reprogramming. Clin Transl Med 12:e747. https:\/\/doi.org\/10.1002\/ctm2.747","journal-title":"Clin Transl Med"},{"key":"6345_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13045-020-00944-9","volume":"13","author":"T Xiao","year":"2020","unstructured":"Xiao T, Xiao Y, Wang W, Tang YY, Xiao Z, Su M (2020) Targeting EphA2 in cancer. J Hematol Oncol 13:114. https:\/\/doi.org\/10.1186\/s13045-020-00944-9","journal-title":"J Hematol Oncol"},{"key":"6345_CR5","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.freeradbiomed.2023.09.008","volume":"208","author":"M-J Kim","year":"2023","unstructured":"Kim M-J, Song Y-R, Kim YE, Bae S-J, Lee W-Y, Bak S-B, Kim YW (2023) Kaempferol stimulation of autophagy regulates the ferroptosis under the oxidative stress as mediated with AMP-activated protein kinase. Free Radic Biol Med 208:630\u2013642. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.09.008","journal-title":"Free Radic Biol Med"},{"key":"6345_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.freeradbiomed.2024.01.002","volume":"213","author":"L Ding","year":"2024","unstructured":"Ding L, Dang S, Sun M, Zhou D, Sun Y, Li E, Peng S, Li J, Li G (2024) Quercetin induces ferroptosis in gastric cancer cells by targeting SLC1A5 and regulating the p-Camk2\/p-DRP1 and NRF2\/GPX4 Axes. Free Radic Biol Med 213:150\u2013163. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.01.002","journal-title":"Free Radic Biol Med"},{"key":"6345_CR7","doi-asserted-by":"publisher","unstructured":"Li Y, Du Y, Zhou Y, Chen Q, Luo Z, Ren Y, Chen X, Chen G (2023) Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death. Cell Commun Signal 21. https:\/\/doi.org\/10.1186\/s12964-023-01267-1","DOI":"10.1186\/s12964-023-01267-1"},{"key":"6345_CR8","doi-asserted-by":"publisher","first-page":"101697","DOI":"10.1016\/j.redox.2020.101697","volume":"37","author":"J Lee","year":"2020","unstructured":"Lee J, You JH, Kim M-S, Roh J-L (2020) Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer. Redox Biol 37:101697. https:\/\/doi.org\/10.1016\/j.redox.2020.101697","journal-title":"Redox Biol"},{"key":"6345_CR9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B (2021) Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12:599\u2013620. https:\/\/doi.org\/10.1007\/s13238-020-00789-5","journal-title":"Protein Cell"},{"key":"6345_CR10","doi-asserted-by":"publisher","first-page":"101799","DOI":"10.1016\/j.redox.2020.101799","volume":"37","author":"Q Kang","year":"2020","unstructured":"Kang Q, Yang C (2020) Oxidative stress and diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol 37:101799. https:\/\/doi.org\/10.1016\/j.redox.2020.101799","journal-title":"Redox Biol"},{"key":"6345_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","volume":"21","author":"H Sies","year":"2020","unstructured":"Sies H, Jones DP (2020) Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol 21:363\u2013383. https:\/\/doi.org\/10.1038\/s41580-020-0230-3","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6345_CR12","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s12276-022-00829-6","volume":"54","author":"Q Xiang","year":"2022","unstructured":"Xiang Q, Zhao Y, Lin J, Jiang S, Li W (2022) The Nrf2 antioxidant defense system in intervertebral disc degeneration: molecular insights. Exp Mol Med 54:1067\u20131075. https:\/\/doi.org\/10.1038\/s12276-022-00829-6","journal-title":"Exp Mol Med"},{"key":"6345_CR13","doi-asserted-by":"publisher","unstructured":"Yao X, Li W, Fang D, Xiao C, Wu X, Li M, Luo Z (2021) Emerging roles of energy metabolism in ferroptosis regulation of tumor cells. Adv Sci (Weinh) 8. https:\/\/doi.org\/10.1002\/advs.202100997","DOI":"10.1002\/advs.202100997"},{"key":"6345_CR14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1186\/s12967-024-05714-6","volume":"22","author":"H Ye","year":"2024","unstructured":"Ye H, Ding X, Lv X, Du Y, Guo R, Qiu J, Li R, Cao L (2024) KLF14 directly downregulates the expression of GPX4 to exert antitumor effects by promoting ferroptosis in cervical cancer. J Transl Med 22:923. https:\/\/doi.org\/10.1186\/s12967-024-05714-6","journal-title":"J Transl Med"},{"key":"6345_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12967-024-05112-y","volume":"22","author":"Z Li","year":"2024","unstructured":"Li Z, Lu W, Yin F, Zeng P, Li H, Huang A (2024) Overexpression of TNFSF11 reduces GPX4 levels and increases sensitivity to ferroptosis inducers in lung adenocarcinoma. J Transl Med 22:340. https:\/\/doi.org\/10.1186\/s12967-024-05112-y","journal-title":"J Transl Med"},{"key":"6345_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cac2.12516","volume":"44","author":"F-H Wang","year":"2024","unstructured":"Wang F-H, Zhang X-T, Tang L, Wu Q, Cai M-Y, Li Y-F, Qu X-J, Qiu H, Zhang Y-J, Ying J-E, Zhang J, Sun L-Y, Lin R-B, Wang C, Liu H, Qiu M-Z, Guan W-L, Rao S-X, Ji J-F, Xin Y, Sheng W-Q, Xu H-M, Zhou Z-W, Zhou A-P, Jin J, Yuan X-L, Bi F, Liu T-S, Liang H, Zhang Y-Q, Li G-X, Liang J, Liu B-R, Shen L, Li J, Xu R-H (2024) The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer Commun (Lond) 44:127\u2013172. https:\/\/doi.org\/10.1002\/cac2.12516","journal-title":"Cancer Commun (Lond)"},{"key":"6345_CR17","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1007\/s13277-015-4139-y","volume":"37","author":"H-M Yi","year":"2016","unstructured":"Yi H-M, Yi H, Zhu J-F, Xiao T, Lu S-S, Guan Y-J, Xiao Z-Q (2016) A five-variable signature predicts radioresistance and prognosis in nasopharyngeal carcinoma patients receiving radical radiotherapy. Tumour Biol 37:2941\u20132949. https:\/\/doi.org\/10.1007\/s13277-015-4139-y","journal-title":"Tumour Biol"},{"key":"6345_CR18","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1107\/S2059798322002741","volume":"78","author":"G Jones","year":"2022","unstructured":"Jones G, Jindal A, Ghani U, Kotelnikov S, Egbert M, Hashemi N, Vajda S, Padhorny D, Kozakov D (2022) Elucidation of protein function using computational docking and hotspot analysis by ClusPro and FTMap. Acta Crystallogr D Struct Biol 78:690\u2013697. https:\/\/doi.org\/10.1107\/S2059798322002741","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"6345_CR19","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.str.2020.06.006","volume":"28","author":"IT Desta","year":"2020","unstructured":"Desta IT, Porter KA, Xia B, Kozakov D, Vajda S (2020) Performance and its limits in rigid body protein-protein docking. Structure 28:1071\u20131081e3. https:\/\/doi.org\/10.1016\/j.str.2020.06.006","journal-title":"Structure"},{"key":"6345_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/prot.25219","volume":"85","author":"S Vajda","year":"2017","unstructured":"Vajda S, Yueh C, Beglov D, Bohnuud T, Mottarella SE, Xia B, Hall DR, Kozakov D (2017) New additions to the ClusPro server motivated by CAPRI. Proteins 85:435\u2013444. https:\/\/doi.org\/10.1002\/prot.25219","journal-title":"Proteins"},{"key":"6345_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, Beglov D, Vajda S (2017) The ClusPro web server for protein-protein docking. Nat Protoc 12:255\u2013278. https:\/\/doi.org\/10.1038\/nprot.2016.169","journal-title":"Nat Protoc"},{"key":"6345_CR22","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","volume":"15","author":"M Conrad","year":"2019","unstructured":"Conrad M, Pratt DA (2019) The chemical basis of ferroptosis. Nat Chem Biol 15:1137\u20131147. https:\/\/doi.org\/10.1038\/s41589-019-0408-1","journal-title":"Nat Chem Biol"},{"key":"6345_CR23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, Shen J, Jiang J, Wang F, Min J (2023) Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther 8:372. https:\/\/doi.org\/10.1038\/s41392-023-01606-1","journal-title":"Signal Transduct Target Ther"},{"key":"6345_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2013.03.019","volume":"61","author":"L Di Cesare Mannelli","year":"2013","unstructured":"Di Cesare Mannelli L, Zanardelli M, Failli P, Ghelardini C (2013) Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: could it correlate with in vivo neuropathy? Free Radic Biol Med 61:143\u2013150. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.03.019","journal-title":"Free Radic Biol Med"},{"key":"6345_CR25","doi-asserted-by":"publisher","first-page":"e2118300119","DOI":"10.1073\/pnas.2118300119","volume":"119","author":"EM Burton","year":"2022","unstructured":"Burton EM, Voyer J, Gewurz BE (2022) Epstein-Barr virus latency programs dynamically sensitize B cells to ferroptosis. Proc Natl Acad Sci U S A 119:e2118300119. https:\/\/doi.org\/10.1073\/pnas.2118300119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6345_CR26","doi-asserted-by":"publisher","unstructured":"Gao M, Yi J, Zhu J, Minikes AM, Monian P, Thompson CB, Jiang X (2019) Role of mitochondria in ferroptosis. Mol Cell 73:354+. https:\/\/doi.org\/10.1016\/j.molcel.2018.10.042","DOI":"10.1016\/j.molcel.2018.10.042"},{"key":"6345_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lu S, Wu L-L, Yang L, Yang L, Wang J (2023) The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis 14:519. https:\/\/doi.org\/10.1038\/s41419-023-06045-y","journal-title":"Cell Death Dis"},{"key":"6345_CR28","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","volume":"82","author":"D Liang","year":"2022","unstructured":"Liang D, Minikes AM, Jiang X (2022) Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell 82:2215\u20132227. https:\/\/doi.org\/10.1016\/j.molcel.2022.03.022","journal-title":"Mol Cell"},{"key":"6345_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"W-L Guan","year":"2023","unstructured":"Guan W-L, He Y, Xu R-H (2023) Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol 16:57. https:\/\/doi.org\/10.1186\/s13045-023-01451-3","journal-title":"J Hematol Oncol"},{"key":"6345_CR30","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","volume":"7","author":"W-H Yang","year":"2021","unstructured":"Yang W-H, Qiu Y, Stamatatos O, Janowitz T, Lukey MJ (2021) Enhancing the efficacy of glutamine metabolism inhibitors in cancer therapy. Trends Cancer 7:790\u2013804. https:\/\/doi.org\/10.1016\/j.trecan.2021.04.003","journal-title":"Trends Cancer"},{"key":"6345_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13046-015-0221-y","volume":"34","author":"GJ Yoshida","year":"2015","unstructured":"Yoshida GJ (2015) Metabolic reprogramming: the emerging concept and associated therapeutic strategies. J Exp Clin Cancer Res 34:111. https:\/\/doi.org\/10.1186\/s13046-015-0221-y","journal-title":"J Exp Clin Cancer Res"},{"key":"6345_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41392-021-00581-9","volume":"6","author":"J Wu","year":"2021","unstructured":"Wu J, Yeung S-CJ, Liu S, Qdaisat A, Jiang D, Liu W, Cheng Z, Liu W, Wang H, Li L, Zhou Z, Liu R, Yang C, Chen C, Yang R (2021) Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORC1 and scavenging ROS. Signal Transduct Target Ther 6:188. https:\/\/doi.org\/10.1038\/s41392-021-00581-9","journal-title":"Signal Transduct Target Ther"},{"key":"6345_CR33","doi-asserted-by":"publisher","first-page":"2454887","DOI":"10.1080\/13510002.2025.2454887","volume":"30","author":"K Kato","year":"2025","unstructured":"Kato K, Yasui H, Sato-Akaba H, Emoto MC, Fujii HG, Kmiec MM, Kuppusamy P, Nagane M, Yamashita T, Inanami O (2025) Non-invasive electron paramagnetic resonance imaging detects tumor redox imbalance induced by ferroptosis. Redox Rep 30:2454887. https:\/\/doi.org\/10.1080\/13510002.2025.2454887","journal-title":"Redox Rep"},{"key":"6345_CR34","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.arr.2012.10.004","volume":"12","author":"V Sosa","year":"2013","unstructured":"Sosa V, Molin\u00e9 T, Somoza R, Paciucci R, Kondoh H, LLeonart ME (2013) Oxidative stress and cancer: an overview. Ageing Res Rev 12:376\u2013390. https:\/\/doi.org\/10.1016\/j.arr.2012.10.004","journal-title":"Ageing Res Rev"},{"key":"6345_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/imr.13280","volume":"321","author":"J Le","year":"2024","unstructured":"Le J, Pan G, Zhang C, Chen Y, Tiwari AK, Qin J-J (2024) Targeting ferroptosis in gastric cancer: strategies and opportunities. Immunol Rev 321:228\u2013245. https:\/\/doi.org\/10.1111\/imr.13280","journal-title":"Immunol Rev"},{"key":"6345_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R (2022) Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer 21:47. https:\/\/doi.org\/10.1186\/s12943-022-01530-y","journal-title":"Mol Cancer"},{"key":"6345_CR37","doi-asserted-by":"publisher","first-page":"110676","DOI":"10.1016\/j.biopha.2020.110676","volume":"131","author":"D Xue","year":"2020","unstructured":"Xue D, Zhou X, Qiu J (2020) Emerging role of NRF2 in ROS-mediated tumor chemoresistance. Biomed Pharmacother 131:110676. https:\/\/doi.org\/10.1016\/j.biopha.2020.110676","journal-title":"Biomed Pharmacother"},{"key":"6345_CR38","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1158\/0008-5472.CAN-16-2675","volume":"77","author":"M Vouri","year":"2017","unstructured":"Vouri M, Hafizi S (2017) TAM receptor tyrosine kinases in cancer drug resistance. Cancer Res 77:2775\u20132778. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2675","journal-title":"Cancer Res"},{"key":"6345_CR39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1172\/JCI33154","volume":"118","author":"DM Brantley-Sieders","year":"2008","unstructured":"Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JMM, Coffman K, Jackson D, Bruckheimer E, Muraoka-Cook RS, Chen J (2008) The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. J Clin Invest 118:64\u201378. https:\/\/doi.org\/10.1172\/JCI33154","journal-title":"J Clin Invest"},{"key":"6345_CR40","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","volume":"12","author":"D Du","year":"2022","unstructured":"Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, Hao H, Xiong J (2022) Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm Sin B 12:558\u2013580. https:\/\/doi.org\/10.1016\/j.apsb.2021.09.019","journal-title":"Acta Pharm Sin B"},{"key":"6345_CR41","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1016\/j.ymthe.2020.08.021","volume":"28","author":"J Liu","year":"2020","unstructured":"Liu J, Xia X, Huang P (2020) xCT: a critical molecule that links cancer metabolism to redox signaling. Mol Ther 28:2358\u20132366. https:\/\/doi.org\/10.1016\/j.ymthe.2020.08.021","journal-title":"Mol Ther"},{"key":"6345_CR42","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1038\/s41467-023-39401-9","volume":"14","author":"Y Yan","year":"2023","unstructured":"Yan Y, Teng H, Hang Q, Kondiparthi L, Lei G, Horbath A, Liu X, Mao C, Wu S, Zhuang L, James You M, Poyurovsky MV, Ma L, Olszewski K, Gan B (2023) SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells. Nat Commun 14:3673. https:\/\/doi.org\/10.1038\/s41467-023-39401-9","journal-title":"Nat Commun"},{"key":"6345_CR43","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1038\/s41418-019-0274-0","volume":"26","author":"C Li","year":"2019","unstructured":"Li C, Chen H, Lan Z, He S, Chen R, Wang F, Liu Z, Li K, Cheng L, Liu Y, Sun K, Wan X, Chen X, Peng H, Li L, Zhang Y, Jing Y, Huang M, Wang Y, Wang Y, Jiang J, Zha X, Chen L, Zhang H (2019) mTOR-dependent upregulation of xCT blocks melanin synthesis and promotes tumorigenesis. Cell Death Differ 26:2015\u20132028. https:\/\/doi.org\/10.1038\/s41418-019-0274-0","journal-title":"Cell Death Differ"},{"key":"6345_CR44","doi-asserted-by":"publisher","first-page":"115241","DOI":"10.1016\/j.bcp.2022.115241","volume":"205","author":"J He","year":"2022","unstructured":"He J, Wang X, Chen K, Zhang M, Wang J (2022) The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment. Biochem Pharmacol 205:115241. https:\/\/doi.org\/10.1016\/j.bcp.2022.115241","journal-title":"Biochem Pharmacol"},{"key":"6345_CR45","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41420-024-01993-6","volume":"10","author":"W Liu","year":"2024","unstructured":"Liu W, Liu C, Xiao J, Qian C, Chen Z, Lin W, Zhang Y, Wu J, Zhou R, Zhao L (2024) HTRA1 interacts with SLC7A11 to modulate colorectal cancer chemosensitivity by inhibiting ferroptosis. Cell Death Discov 10:228. https:\/\/doi.org\/10.1038\/s41420-024-01993-6","journal-title":"Cell Death Discov"},{"key":"6345_CR46","doi-asserted-by":"publisher","first-page":"101801","DOI":"10.1016\/j.redox.2020.101801","volume":"38","author":"L Ma","year":"2021","unstructured":"Ma L, Chen T, Zhang X, Miao Y, Tian X, Yu K, Xu X, Niu Y, Guo S, Zhang C, Qiu S, Qiao Y, Fang W, Du L, Yu Y, Wang J (2021) The m(6)A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function. Redox Biol 38:101801. https:\/\/doi.org\/10.1016\/j.redox.2020.101801","journal-title":"Redox Biol"},{"key":"6345_CR47","doi-asserted-by":"publisher","first-page":"2290864","DOI":"10.1080\/13510002.2023.2290864","volume":"29","author":"H Zan","year":"2024","unstructured":"Zan H, Liu J, Yang M, Zhao H, Gao C, Dai Y, Wang Z, Liu H, Zhang Y (2024) Melittin alleviates sepsis-induced acute kidney injury by promoting GPX4 expression to inhibit ferroptosis. Redox Rep 29:2290864. https:\/\/doi.org\/10.1080\/13510002.2023.2290864","journal-title":"Redox Rep"},{"key":"6345_CR48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.tibs.2018.01.006","volume":"43","author":"Z Lu","year":"2018","unstructured":"Lu Z, Hunter T (2018) Metabolic kinases moonlighting as protein kinases. Trends Biochem Sci 43:301\u2013310. https:\/\/doi.org\/10.1016\/j.tibs.2018.01.006","journal-title":"Trends Biochem Sci"},{"key":"6345_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","volume":"24","author":"GR Steinberg","year":"2023","unstructured":"Steinberg GR, Hardie DG (2023) New insights into activation and function of the AMPK. Nat Rev Mol Cell Biol 24:255\u2013272. https:\/\/doi.org\/10.1038\/s41580-022-00547-x","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6345_CR50","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","volume":"7","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, Wang Y, Fu C, Jiang Y, He C, Wei Q (2022) Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther 7:78. https:\/\/doi.org\/10.1038\/s41392-022-00925-z","journal-title":"Signal Transduct Target Ther"},{"key":"6345_CR51","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41571-023-00813-7","volume":"20","author":"D DeRyckere","year":"2023","unstructured":"DeRyckere D, Huelse JM, Earp HS, Graham DK (2023) TAM family kinases as therapeutic targets at the interface of cancer and immunity. Nat Rev Clin Oncol 20:755\u2013779. https:\/\/doi.org\/10.1038\/s41571-023-00813-7","journal-title":"Nat Rev Clin Oncol"},{"key":"6345_CR52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41573-020-0082-8","volume":"20","author":"AA Zarrin","year":"2021","unstructured":"Zarrin AA, Bao K, Lupardus P, Vucic D (2021) Kinase inhibition in autoimmunity and inflammation. Nat Rev Drug Discov 20:39\u201363. https:\/\/doi.org\/10.1038\/s41573-020-0082-8","journal-title":"Nat Rev Drug Discov"},{"key":"6345_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/bs.apcsb.2020.11.001","volume":"124","author":"P Gupta","year":"2021","unstructured":"Gupta P, Taiyab A, Hassan MI (2021) Emerging role of protein kinases in diabetes mellitus: from mechanism to therapy. Adv Protein Chem Struct Biol 124:47\u201385. https:\/\/doi.org\/10.1016\/bs.apcsb.2020.11.001","journal-title":"Adv Protein Chem Struct Biol"},{"key":"6345_CR54","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1042\/EBC20220002","volume":"66","author":"CN Chu","year":"2022","unstructured":"Chu CN, Lee TKW (2022) Targeting protein kinases in cancer stem cells. Essays Biochem 66:399\u2013412. https:\/\/doi.org\/10.1042\/EBC20220002","journal-title":"Essays Biochem"},{"key":"6345_CR55","doi-asserted-by":"publisher","first-page":"188738","DOI":"10.1016\/j.bbcan.2022.188738","volume":"1877","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Bu L, Luo J, Guo J (2022) Targeting protein kinases benefits cancer immunotherapy. Biochim Biophys Acta Rev Cancer 1877:188738. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188738","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"6345_CR56","doi-asserted-by":"publisher","unstructured":"Wu L, Ou Z, Liu P, Zhao C, Tong S, Wang R, Li Y, Yuan J, Chen M, Fan B, Zu X, Wang Y, Tang J (2023) ATXN3 promotes prostate cancer progression by stabilizing YAP. Cell Commun Signal 21. https:\/\/doi.org\/10.1186\/s12964-023-01073-9","DOI":"10.1186\/s12964-023-01073-9"},{"key":"6345_CR57","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13046-023-02805-y","volume":"42","author":"H Gao","year":"2023","unstructured":"Gao H, Yin J, Ji C, Yu X, Xue J, Guan X, Zhang S, Liu X, Xing F (2023) Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application. J Exp Clin Cancer Res 42:225. https:\/\/doi.org\/10.1186\/s13046-023-02805-y","journal-title":"J Exp Clin Cancer Res"},{"key":"6345_CR58","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/s41467-022-29846-9","volume":"13","author":"Z Ning","year":"2022","unstructured":"Ning Z, Guo X, Liu X, Lu C, Wang A, Wang X, Wang W, Chen H, Qin W, Liu X, Zhou L, Ma C, Du J, Lin Z, Luo H, Otkur W, Qi H, Chen D, Xia T, Liu J, Tan G, Xu G, Piao H-L (2022) USP22 regulates lipidome accumulation by stabilizing PPAR\u03b3 in hepatocellular carcinoma. Nat Commun 13:2187. https:\/\/doi.org\/10.1038\/s41467-022-29846-9","journal-title":"Nat Commun"},{"key":"6345_CR59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bcp.2017.02.011","volume":"131","author":"T An","year":"2017","unstructured":"An T, Gong Y, Li X, Kong L, Ma P, Gong L, Zhu H, Yu C, Liu J, Zhou H, Mao B, Li Y (2017) USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth. Biochem Pharmacol 131:29\u201339. https:\/\/doi.org\/10.1016\/j.bcp.2017.02.011","journal-title":"Biochem Pharmacol"},{"key":"6345_CR60","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhou X, Xie F, Zhang L, Yan H, Huang J, Zhang C, Zhou F, Chen J, Zhang L (2022) Ferroptosis in cancer and cancer immunotherapy. Cancer Commun (Lond) 42:88\u2013116. https:\/\/doi.org\/10.1002\/cac2.12250","journal-title":"Cancer Commun (Lond)"},{"key":"6345_CR61","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.drup.2022.100916","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J, Wang H (2023) Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat 66:100916. https:\/\/doi.org\/10.1016\/j.drup.2022.100916","journal-title":"Drug Resist Updat"},{"key":"6345_CR62","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2147\/IJN.S445333","volume":"19","author":"Z Dong","year":"2024","unstructured":"Dong Z, Zhang X, Zhang Q, Tangthianchaichana J, Guo M, Du S, Lu Y (2024) Anticancer mechanisms and potential anticancer applications of antimicrobial peptides and their nano agents. Int J Nanomed 19:1017\u20131039. https:\/\/doi.org\/10.2147\/IJN.S445333","journal-title":"Int J Nanomed"},{"key":"6345_CR63","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jconrel.2017.02.006","volume":"250","author":"S Dissanayake","year":"2017","unstructured":"Dissanayake S, Denny WA, Gamage S, Sarojini V (2017) Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides. J Control Release 250:62\u201376. https:\/\/doi.org\/10.1016\/j.jconrel.2017.02.006","journal-title":"J Control Release"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06345-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06345-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06345-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:30:55Z","timestamp":1789979455000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06345-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6345"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06345-4","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This project collected clinical samples and was approved by the Medical Ethics Committee of Xiangya Hospital, Central South University (No. 2023030512). Participants were informed of the experimental content and signed an informed consent form. The animal procedures were approved by the Animal Ethics and welfare Committee, at Central South University (No. 2023030512). All animal studies were carried out using the Institutional Animal Care and Use Committee (IACUC) approved procedures.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consented for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests or personal relationships that could have influenced the reported work in this paper.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"341"}}